July 10 (Reuters) - Elevar Therapeutics and Hengrui suffered a fresh setback on Friday after the U.S. FDA declined to approve ...

A new study links drinking up to five cups of coffee daily with a significantly lower risk of liver disease, liver cancer, ...

The third time is not the charm for Hengrui Pharma and Elevar Therapeutics’ star-crossed combination of camrelizumab and ...

Patients with very early or early-stage hepatocellular carcinoma have similar survival with external beam radiation as they ...

Investigators at Cedars Sinai analyzed long-term health outcomes, liver MRI scans, and blood proteins, finding new evidence ...

Liver cancer often develops silently, with symptoms appearing only when the disease has progressed. Unexplained weight loss, ...

Liver cancer is a lethal disease with limited treatment options for advanced stages. While risk factors such as viral hepatitis, alcohol use, and obesity increase the likelihood of hepatocellular ...

Anna's story began in 2022, when she was diagnosed with Hepatitis B, a viral infection that, if left untreated, can silently ...

Silent liver disease may affect 1 in 60 adults over 40, and researchers say early screening could catch damage before ...

Immune checkpoint blockade (ICB) has reshaped the treatment landscape for advanced hepatocellular carcinoma (HCC), offering ...

Fatty liver disease can fuel the most aggressive form of colon cancer, a new study says. People with fatty liver disease are ...